Reslizumab (Cinqair) for Eosinophilic Asthma

Am Fam Physician. 2017 Nov 15;96(10):671-672.
No abstract available

MeSH terms

  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / complications
  • Asthma / drug therapy*
  • Eosinophilia / complications
  • Humans

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • reslizumab